Search

everythinglearnresearchcommunity

for

Search:↓

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Ruxolitinib can help regrow hair in severe alopecia areata.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Baricitinib was effective in treating both early and late onset alopecia areata.

Melatonin may protect hair follicle stem cells from damage caused by chemotherapy.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.